Company Filing History:
Years Active: 2015
Title: Laura W. Andraka: Innovator in TRPM8 Antagonists
Introduction
Laura W. Andraka, a distinguished inventor based in Tucson, AZ, has made significant contributions to the field of pharmaceutical innovations. With a focus on understanding and treating TRPM8-mediated disorders, her work has the potential to transform pain management and therapeutic approaches in various medical conditions.
Latest Patents
Laura holds a patent for "Cold menthol receptor-1 antagonists," which specifically addresses TRPM8 antagonists of Formula (I). The invention encompasses novel compounds, methods for preparing these compounds, compositions, intermediates, and derivatives. Additionally, it describes pharmaceutical and veterinary compositions along with methods for treating pain and various disease states or conditions associated with TRPM8.
Career Highlights
Currently, Laura W. Andraka is affiliated with Janssen Pharmaceutica NV, a renowned company dedicated to creating innovative medicines. Her career in the pharmaceutical industry highlights her commitment to advancing healthcare solutions through research and development.
Collaborations
In her professional journey, Laura collaborates with accomplished colleagues, including Raymond W. Colburn and Scott L. Dax. These partnerships enhance her research endeavors and foster a collaborative environment conducive to innovation.
Conclusion
Laura W. Andraka is a pivotal figure in the realm of medicinal chemistry and innovation. Her patents not only exemplify her creative prowess but also showcase the promising advancements in treating TRPM8-related disorders. Through her ongoing work at Janssen Pharmaceutica NV, she continues to impact the pharmaceutical landscape positively.